Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001213900-18-003149
Filing Date
2018-03-19
Accepted
2018-03-19 16:44:03
Documents
54
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO QUARTERLY REPORT f10q0317a1_americanbrivision.htm 10-Q/A 357682
2 CERTIFICATION f10q0317a1ex31-1_americanb.htm EX-31.1 9345
3 CERTIFICATION f10q0317a1ex31-2_americanb.htm EX-31.2 9755
4 CERTIFICATION f10q0317a1ex32-1_americanb.htm EX-32.1 3830
5 CERTIFICATION f10q0317a1ex32-2_americanb.htm EX-32.2 3735
  Complete submission text file 0001213900-18-003149.txt   2927991

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE mtoo-20170331.xml EX-101.INS 555261
7 XBRL SCHEMA FILE mtoo-20170331.xsd EX-101.SCH 32447
8 XBRL CALCULATION FILE mtoo-20170331_cal.xml EX-101.CAL 27621
9 XBRL DEFINITION FILE mtoo-20170331_def.xml EX-101.DEF 99679
10 XBRL LABEL FILE mtoo-20170331_lab.xml EX-101.LAB 206847
11 XBRL PRESENTATION FILE mtoo-20170331_pre.xml EX-101.PRE 193164
Mailing Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924
Business Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924 845-551-8728
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 333-91436 | Film No.: 18699314
SIC: 2834 Pharmaceutical Preparations